Outcome at Two Years of Very Preterm Infants Born after Rupture of Membranes before Viability

International audienc

Comparison of neonatal complications.

<p>WG: weeks of gestation; A/S: Affected/Survivors; <b>*</b> Inflammatory disease: Periventricular leukomalacia, and/or IVH and/or chronic lung disease and/or necrotizing enterocolitis and/or death.</p

Comparison of maternal, pregnancy and labour characteristics.

<p>SD: standard deviation; ^<b>1</b> Repetitive urinary or vaginal infections; ^<b>2</b> Uterus malformation, cervix insufficiency, conisation; ^<b>3</b> Interruption of pregnancy, C section, preterm birth; <b>*</b> non interpretable.</p

Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?

We investigate the concordance, in terms of favoring the same treatment arm, between clinician-reported symptomatic adverse events (AEs) and information obtained via patient-reported outcomes (PRO) measures in cancer randomized controlled trials (RCTs)